no it's not, it was highlighted in their last quarterly last year they were expecting a R&D rebate
- Forums
- ASX - By Stock
- TYP
- Ex1 Chart
Ex1 Chart, page-65
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TYP (ASX) to my watchlist
|
|||||
Last
2.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $22.87M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 49047 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 125000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 49047 | 0.021 |
3 | 1005500 | 0.020 |
4 | 594980 | 0.019 |
2 | 126509 | 0.018 |
1 | 275000 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 125000 | 1 |
0.023 | 704434 | 3 |
0.024 | 590529 | 3 |
0.025 | 466164 | 2 |
0.026 | 803000 | 2 |
Last trade - 16.34pm 09/08/2024 (20 minute delay) ? |
Featured News
BOE
Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan
NEU
Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
TYP (ASX) Chart |
Day chart unavailable